Joshua Monrad
Co-founder and managing director, Sentinel Bio
Titles as the sources gave them. In 1 entry, with 5 checked quotations.
What they said
Newest first. Each quotation was found word for word in the source.
“I think it's clear the models are misaligned or not well enough aligned that we could have something like an incident.”
“I just genuinely think that uplift is sort of a lagging indicator. Again, these studies take a long time to conduct and then they take a long time to release”
Speaker known from context, not confirmed by listening
“I think it's better than actively training on it in the first place, but uh if the data is just like readily accessible, you haven't really caused that much friction for attackers.”
Speaker known from context, not confirmed by listening
“I would absolutely if I were holding that button, I would absolutely press it.”
“how can we make it so that the vast majority of providers of, you know, north of 80% of providers of certain materials and services such as synthetic DNA or cloud labs are both doing the kind of KYC that would allow them to refuse an illegitimate uh query”
Speaker known from context, not confirmed by listening
In the Base
Every entry they appear in.
KYC Becomes KYA: Sentinel Bio's Joshua Monrad on DNA Screening, Uplift Studies & Agent Monitoring
In a long interview with host Nathan Labenz, Sentinel Bio's Joshua Monrad says AI-enabled biological attacks are held back mainly by lab robotics, not intelligence, and that knowledge barriers are eroding. Monrad backs DNA-synthesis screening and customer checks, and says Monrad would press a pause button on frontier AI for biology.